Stocks and Investing Stocks and Investing
Tue, November 1, 2022
[ 12:00 AM ] - WOPRAI
Etzer Darout Maintained (YMAB) at Buy with Decreased Target to $12 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Tyler Radke Maintained (TDC) at Strong Buy with Decreased Target to $40 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Christopher Horvers Maintained (TCS) at Sell with Decreased Target to $75 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Salim Syed Maintained (BIIB) at Strong Buy with Increased Target to $325 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Tyler Radke Maintained (CCCS) at Hold with Decreased Target to $10 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
John Roberts Initiated (CC) at Sell and Held Target at $24 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Paul Quinn Downgraded (CLW) to Hold and Held Target at $45 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Mark Wilde Maintained (CLW) at Buy with Increased Target to $52 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
John Eade Maintained (SPGI) at Strong Buy with Decreased Target to $365 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Richard Hill Maintained (DOC) at Hold with Decreased Target to $15 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Barton Crockett Maintained (SPOT) at Hold with Decreased Target to $87 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Yaron Werber Downgraded (TIL) to Hold on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Jack Allen Maintained (TIL) at Buy with Decreased Target to $480 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Vikram Purohit Maintained (TIL) at Hold with Decreased Target to $120 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Jamie Perse Maintained (THC) at Strong Buy with Decreased Target to $80 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Catherine Ramsey Maintained (TMO) at Buy with Decreased Target to $665 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Harry Fong Maintained (TRV) at Strong Buy with Increased Target to $220 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
John Roberts Initiated (TROX) at Sell and Held Target at $10 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Trey Grooms Maintained (TREX) at Buy with Decreased Target to $53 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Alex Rygiel Maintained (TREX) at Strong Buy with Decreased Target to $58 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Stanley Elliott Maintained (TREX) at Strong Buy with Decreased Target to $60 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Michael Cyprys Maintained (TW) at Buy with Decreased Target to $85 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Rick Schafer Maintained (VECO) at Buy with Decreased Target to $30 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Jamie Perse Maintained (UHS) at Strong Sell with Increased Target to $121 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Walter Spracklin Downgraded (UNP) to Sell and Decreased Target to $187 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Esther Hong Initiated (ATAI) at Strong Buy and Held Target at $18 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Gabe Hajde Maintained (ATR) at Buy with Decreased Target to $109 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Daniel Ford Maintained (AWK) at Hold with Increased Target to $151 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Michael Gaugler Maintained (AWK) at Strong Buy with Increased Target to $185 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
James Molloy Initiated (AKTX) at Strong Buy and Held Target at $80 on, Nov 1st, 2022

James Molloy Initiated (AKTX) at Strong Buy and Held Target at $80 on, Nov 1st, 2022


Published on 2024-10-27 23:48:26 - WOPRAI, James Molloy
  Print publication without navigation


James Molloy of Alliance Global Partners, Initiated "Akari Therapeutics, Plc" (AKTX) at Strong Buy and Held Target at $80 on, Nov 1st, 2022.

James, nor any peers, have made any analyst calls on AKTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources